Screener
Idexx Laboratories IDXX Income Statement
| Q2 '26 | Q1 '26 | Q4 '25 | Q3 '25 | Q2 '25 | ||
|---|---|---|---|---|---|---|
| $1.22B+9.7% | $1.14B+14.3% | $1.09B+14.3% | $1.11B+13.3% | $1.11B+10.6% | ||
| $437.5M+5.5% | $418.08M+11.5% | $432.47M+12.7% | $421.89M+11.2% | $414.73M+7.9% | ||
| $779.09M+12.1% | $722.74M+15.9% | $658.11M+15.3% | $683.35M+14.6% | $694.73M+12.2% | ||
| 64%+1.4pp | 63.4%+0.9pp | 60.3%+0.5pp | 61.8%+0.7pp | 62.6%+0.9pp | ||
| $65.43M+5.7% | $65.79M+11.4% | $66.83M+15.8% | $63.42M+17.5% | $61.9M+11.6% | ||
| $171.28M+6.3% | $175.25M+12.2% | $167.06M+11.3% | $159.16M+8.8% | $161.11M+12.9% | ||
| $116.82M+18.4% | $119.12M+30.1% | $108.62M+7.4% | $105.94M+15.3% | $98.68M-37.2% | ||
| $353.52M+9.9% | $360.15M+17.4% | $342.51M+10.9% | $328.51M+12.4% | $321.69M-9.5% | ||
| $425.57M+14.1% | $362.59M+14.5% | $315.61M+20.6% | $354.85M+16.8% | $373.05M+41.4% | ||
| 35%+1.4pp | 31.8%+0.1pp | 28.9%+1.5pp | 32.1%+1.0pp | 33.6%+7.3pp | ||
| —— | $7.74M+1.0% | $9.21M+22.8% | $10.66M+38.4% | $11.32M+39.8% | ||
| $417.22M+15.1% | $355.44M+14.6% | $306.98M+19.7% | $344.77M+15.3% | $362.35M+39.9% | ||
| $78.81M+15.3% | $77M+14.2% | $58.79M+46.1% | $70.16M+6.2% | $68.36M+22.6% | ||
| $338.41M+15.1% | $278.45M+14.7% | $248.19M+14.8% | $274.61M+17.9% | $293.99M+44.6% | ||
| 27.8%+1.3pp | 24.4%+0.1pp | 22.8%+0.1pp | 24.8%+1.0pp | 26.5%+6.2pp | ||
| $4.27+17.6% | $3.47+17.2% | $3.09+17.9% | $3.40+21.4% | $3.63+48.8% | ||
| $425.57M+14.1% | $362.59M+14.5% | $315.61M+20.6% | $354.85M+16.8% | $373.05M+41.4% |
FAQ
- What is Idexx Laboratories's revenue?
- Idexx Laboratories (IDXX) generated $4.6B in revenue over the trailing twelve months, up 12.8% year over year.
- Is Idexx Laboratories profitable?
- Idexx Laboratories reported $1.1B in net income over the trailing twelve months, a 25.0% net margin.
- What are Idexx Laboratories's profit margins?
- Gross margin is 62.4% and operating margin is 32.0%, with a 25.0% net margin.
- What is Idexx Laboratories's earnings per share?
- Idexx Laboratories's diluted EPS over the trailing twelve months is $14.23.
- Where does Idexx Laboratories's income statement data come from?
- Every line is extracted from Idexx Laboratories's SEC filings (10-K and 10-Q) and tagged in XBRL. Switch between quarterly, annual, and trailing-twelve-month views, or open any line for its full history and peer comparisons.
